⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AXSM News
Axsome Therapeutics, Inc
Agitation in Alzheimer's Disease Market to Register Immense Growth at a CAGR of 14.9% During the Forecast Period (2026-2036) | DelveInsight
prnewswire.com
AXSM
IGC
Form 8-K
sec.gov
AXSM
Form 8-K
sec.gov
AXSM
Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting
globenewswire.com
AXSM
Form 8-K
sec.gov
AXSM
Axsome Therapeutics Announces Settlement Resolving All SUNOSI® (solriamfetol) Patent Litigation
globenewswire.com
AXSM
Axsome Therapeutics Partners with the Headache Alliance to Highlight the Impact of Migraine During Migraine and Headache Awareness Month
globenewswire.com
AXSM
Axsome Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
AXSM
Axsome Therapeutics Presents New AUVELITY® Data in Major Depressive Disorder at the American Society of Clinical Psychopharmacology (ASCP) 2026 Annual Meeting
globenewswire.com
AXSM
Axion Semiconductor Acquires Moov Technologies
prnewswire.com
AXSM